The distribution of anti-CCP2 (Figure 2A) for the patients is clearly more bimodal and with a thinner waist than for IgM RF (Figure 2B), in agreement with studies arguing that ACPA positive and ACPA negative RA are separate disease entities with different genetic and environmental risk factors (84). The gene discussed is AGBL2; the disease is rheumatoid arthritis.